Samedan Ltd Pharmaceutical Publishers


Advanced search

Buy Valtrex Online Buy Cipro without prescription\|Yaz online no prescription \|Buy Clomid no prescription\|Buy Alesse online no prescription\|Buy Armour without prescription\|Buy Dexamethasone without prescription\|Buy Colchicine without prescription \|Buy Prednisolone without prescription\|Buy Synthroid no prescription Buy Mirapex without prescription \|Buy Lamictal no prescription\|Buy Atenolol without prescription Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

home > ebr

PUBLICATIONS

European Biopharmaceutical Review

European Biopharmaceutical Review (EBR) is a journal designed to fill a unique position in scientific publishing. Published quarterly, it provides a dedicated platform of communication and information for the European biopharmaceutical market across Europe, North America & the rest of the world.

With editorial consisting of in-depth articles, case studies, meeting and report reviews written by specialists with hands-on experience in the biopharmaceutical industry, traditional multi-national pharmaceutical companies, investment houses and industry-associated governmental, economic and societal bodies. Each quarterly edition examines topical areas of importance across the board of biopharmaceutical research and development, with regular feature sections on BioBusiness Development, Research and Innovation, BioDiscovery, BioManufacturing plus special focuses on geographic or therapeutic territories.

For further information please contact:
Advertising David Hirsh Kenneth Gills	Editorial Sonia Sharma

View the
digital version
of EBR

	Subscribe
	Current Issue
	Archives
	Media Info
	Our Clients

Featured in this issue

BioFormulation and Manufacturing
Market Authorisation

Gaining Approval

Thilo Kaltenbach at Arthur D. Little Healthcare assesses how Big Pharma can implement specific policies to ensure that a new drug is successfully authorised.

STRATEGY AND FINANCE

Strategy and Finance

Rising Up: Part 1

Mounting healthcare costs in the US are prompting a change from free-pricing to value-based pricing of pharmaceuticals, as Graham Scholefield and Markus Thunecke at Catenion demonstrate.

BioBusiness Development

Research and Development

Collaboration Schemes

The diminishing number of new drugs reaching the market, combined with decreasing R&D productivity and a low return on investment, makes Big Pharma an uncertain environment. Nicolas Carboni at SATT Conectus Alsace highlights a key factor in steering the industry back on track.

Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd

Published quarterly in
January, April,
July and October

Industry Events

Genomics Research 2014

29-30 April 2014, South San Francisco Conference Center, San Francisco, CA, USA

SELECTBIO’s Genomics Research 2014 conference will feature an integrated program of tracks designed to cover the latest developments in single cell PCR, qPCR in diagnostics, next-generation sequencing platforms and methods, microRNA-based gene expression and epigenetics in development.
More info >>

All events >>

News and Press Releases

Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer

REDWOOD CITY, Calif., and (CRAIGAVON, UK) Nov. 25, 2013 -- Genomic Health, Inc. (Nasdaq: GHDX) and ALMAC GROUP Ltd jointly announced today that Genomic Health will exclusively license Almac Group’s technology and intellectual property to further develop, validate and subsequently commercialize a multi-gene test to predict benefit from DNA damage-based chemotherapy drugs, such as the commonly used anthracycline-based regimens, in breast cancer. Such a test would be particularly useful for high-risk breast cancer patients who are eligible for chemotherapy based on their Oncotype DX® score.
More info >>

All releases >>

Air Transport Publications

White Papers

Interface: Drug Delivery Devices

Phillips-Medisize

A family is packing for its annual summer trek to the cottage by the lake. Along with fishing gear, sunscreen, and life vests, the checklist also includes another kind of life saver – an autoinjector that delivers two doses of epinephrine to treat anaphylaxis, a severe and potentially lifethreatening allergic reaction.
More info >>

All white papers >>